Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1975-03-19
1976-08-17
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
424 92, 424 93, 426583, 426585, A61K 3940, A23C 900, A23C 2100
Patent
active
039755177
ABSTRACT:
Preparation of and live bacterial vaccine from selected strains of Escherichia coli. The bacterial cells are treated with dilute formalin solutions (about 0.02 to about 0.08% v/v formalin) for a period to modify the bacteria without inactivation thereof. One preferred strain is EW1 serogroup of 0157. The vaccine has been found particularly effective in preventing the occurrence of enteric colibacillosis in newborn animals. A preferred technique is to vaccinate cows, recover the milk, and continually feed it as a milk replacer to the newborn during the susceptible period.
REFERENCES:
patent: 2110208 (1938-03-01), Eggert
patent: 3127318 (1964-03-01), Eversole et al.
patent: 3128230 (1964-04-01), Heinbach
patent: 3376198 (1968-04-01), Peterson et al.
patent: 3907987 (1975-09-01), Wilson
Wilson et al., Vet. Bul. 41(12), No. 6106, Dec. 1971.
Wilson et al., Vet. Bul. 42(3), No. 1159, Mar. 1972.
Svendson et al., Vet. Bul. 42)3), No. 1154, Mar. 1972.
Wilson et al., Vet. Bul. 42(12), No. 7100, Dec. 1972.
Wilson, Vet. Bul. 43(4), No. 1451, Apr. 1973.
Canadian Patents and Development Limited
Rose Shep K.
Thomson Alan A.
LandOfFree
Enteric disease vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enteric disease vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enteric disease vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486641